Simple Summary In patients with differentiated thyroid cancer, the standard treatment
consists in surgery followed by radioactive iodine (RAI) therapy. Follow-up is usually …

Purpose We investigated whether predictive clinicopathologic factors can be affected by
different response criteria and how the clinical usefulness of radioactive iodine (RAI) therapy …

Background: In patients with differentiated thyroid cancer (DTC) and raising serum
thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an …

BACKGROUND: Differentiated thyroid carcinoma (DTC) with rising thyroglobulin (Tg) level
and negative radioiodine whole body scan results has been observed in follow-up studies …

Abstract Purpose Around 10–27% of patients will present elevated thyroglobulin (Tg) levels
and negative diagnostic whole-body scan (dxWBS) during differentiated thyroid cancer …

Purpose During the follow-up of patients with well-differentiated thyroid carcinoma, some
patients have elevated serum thyroglobulin (Tg) levels without any evidence of radioiodine …

Objective: The prognostic value of stimulated thyroglobulin (sTg) and Tg-related parameters
prior to and immediately after radioactive iodine (RAI) administration was assessed in a …

Currently a trend towards Bde-escalating^ the role of adjuvant iodine-131 (131I) in the
treatment of differentiated thyroid cancer can be observed in the community of clinical …

Background: At present, empirical radioactive iodine therapy is recommended for patients
with thyroid cancer and elevated thyroglobulin (Tg) after initial therapy when neck …

Objective To assess the prognostic value of detectable thyroglobulin (Tg) after initial surgery
and radioactive iodine (131I) therapy by comparing patients with a negative post …